Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Recursion Pharmaceuticals, Inc./ SCHEDULE 13G

SEC Filing · SCHEDULE 13G

Recursion Pharmaceuticals, Inc.

RXRXNASDAQEQUITYCurrent

SEC Filing

Filed Jul 31, 2026Accepted Jul 31, 2026, 10:42 AM EDTCIK 1601830Accession 0002100119-26-001441
View company →Permanent SEC source ↗
Share

Company context

Current securities

RXRXNASDAQ · EQUITY · Current

Recent company filings

  1. Entry into a Material Definitive AgreementSep 21, 2026
  2. 144 filingSep 1, 2026
  3. 10-Q filingAug 5, 2026
  4. Results of Operations and Financial Condition · Regulation FD DisclosureAug 5, 2026
  5. 144 filingAug 4, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗